Immunotherapeutic approaches in pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2008-01-01 / Recent Results Cancer Res. 2008;177:165-77Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes
/in International Publications, Pancreatic Cancer /von 2008-01-01 / Anticancer Res. 2008 Jan-Feb;28(1B):379-87Prostate cancer vaccines: current status and future potential
/in International Publications, Prostate Cancer /von 2008-01-01 / BioDrugs 2008;22(2):71-84Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses
/in International Publications, Malignant Melanoma /von 2008-01-01 / Int. J. Cancer 2008 Jan;122(1):219-29Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients
/in International Publications, Malignant Melanoma /von 2008-01-01 / J. Immunother. 2008 Jan;31(1):101-12Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line
/in Hepatocellular Carcinoma, International Publications /von 2008-01-01 / Hepatogastroenterology 2008 Jan-Feb;55(81):155-9Dendritic cell immunotherapy for malignant gliomas
/in Dendritic Cells, Glioblastoma, International Publications /von 2008-01-01 / Rev Recent Clin Trials 2008 Jan;3(1):10-21
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de